Skip to content
AdminMay 12, 2023 11:24:00 AM< 1 min read

Trends in Genetic Testing for Alzheimer’s

With the approval of new drugs by Eisai and Biogen, genetic testing for Alzheimer’s is on the rise.

This article from Reuters cites a 125% increase in ApoE genetic testing in a four-month period around the approval of the Biogen drug in January. This was determined after review of medical records from nearly 8 million adults across 28 major US hospitals, so it did not account for any increase in DTC genetic testing. Since anti-selection is always a concern, this trend is worth noting.